Abstract
Corticotherapy during pregnancy demonstrates a relative success in reducing mortality and distress respiratory syndrome incidence in the pre-term newborn. In spite of these immediate benefits, it has been described that babies born to betamethasone-treated mothers develop increased cardiovascular risk at the adolescence. Attempting to evaluate whether this cardiovascular risk can be assoc…